LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex

Integrations will Improve Genetic Disease Diagnosis and Coverage of Meaningful Literature ALAMEDA, CALIF. AND ANN ARBOR, MICH. (PRWEB) APRIL 02, 2019 – LifeMap Sciences, the leading integrated biomedical knowledgebase company and a leading provider of tertiary NGS analysis and interpretation solutions for genetic disorders, and Genomenon, the leading genomic search company, announced today that they have entered into... Read more

Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. and ANN ARBOR, Michigan, October 18, 2018 – Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further... Read more

Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service

Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and... Read more

Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels

Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies ANN ARBOR, Michigan – May 23, 2018) – Swift Biosciences—the NGS Library Prep company—and Genomenon—the leading genomic literature search engine company— announced today a new partnership to revolutionize the design of targeted gene... Read more